Janus Henderson Group
KYMR icon

Janus Henderson Group’s Kymera Therapeutics KYMR Stock Holding History

Janus Henderson Group’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.75M Hold
21,058
– – ﹤0.01% 1420
2025
Q4 		$1.64M Buy
21,058
+2,750
+15% +$186K ﹤0.01% 1433
2025
Q3 		$1.04M Sell
18,308
-1,000
-5% -$45.1K ﹤0.01% 1649
2025
Q2 		$842K Sell
19,308
-751,274
-97% -$25.9M ﹤0.01% 1695
2025
Q1 		$22.8M Buy
770,582
+393,198
+104% +$14.3M 0.01% 540
2024
Q4 		$15.2M Buy
377,384
+362,276
+2,398% +$16.4M 0.01% 644
2024
Q3 		$714K Sell
15,108
-3,700
-20% -$163K ﹤0.01% 1848
2024
Q2 		$561K Sell
18,808
-267
-1% -$9.24K ﹤0.01% 1934
2024
Q1 		$766K Buy
19,075
+19
+0.1% +$680 ﹤0.01% 1797
2023
Q4 		$485K Sell
19,056
-35
-0.2% -$626 ﹤0.01% 2002
2023
Q3 		$265K Buy
19,091
+21
+0.1% +$422 ﹤0.01% 2248
2023
Q2 		$438K Buy
19,070
+12
+0.1% +$344 ﹤0.01% 2053
2023
Q1 		$565K Buy
+19,058
New +$615K ﹤0.01% 1942
2022
Q2 		– Sell
-5,588
Closed -$236K – 2640
2022
Q1 		$236K Buy
5,588
+4
+0.1% +$169 ﹤0.01% 2361
2021
Q4 		$355K Buy
+5,584
New +$325K ﹤0.01% 2109
2021
Q2 		– Sell
-397,708
Closed -$15.5M – 1641
2021
Q1 		$15.5M Buy
+397,708
New +$23.9M 0.01% 831

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Janus Henderson Group's KYMR Position: Q1 2026 in Review

Janus Henderson Group held its Kymera Therapeutics (KYMR) position steady in Q1 2026 at 21,058 shares worth $1.75M. The position accounts for ﹤0.01% of the portfolio, ranked #1420.

Janus Henderson Group first reported a position in KYMR in Q1 2021 and has held it in 16 quarters since. The position peaked at $22.8M in Q1 2025. 256 funds tracked by Wall St. Rank hold KYMR as of Q1 2026.

  • Janus Henderson Group held 21,058 shares of Kymera Therapeutics worth $1.75M as of Q1 2026.
  • Janus Henderson Group left its Kymera Therapeutics share count unchanged in Q1 2026.
  • Kymera Therapeutics made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #1420 holding.
  • Janus Henderson Group first reported a position in Kymera Therapeutics in Q1 2021 and has held it in 16 quarters since.
  • Janus Henderson Group's Kymera Therapeutics position peaked at $22.8M in Q1 2025.
  • 256 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.